title: [Should we consider a new classification of diabetes influenced by therapeutic decisions?]
abstract: The growing number of diabetic patients in the whole world causes the problems to allocate some patients into the respective type of diabetes related to the present classification. B cell is considered as the central cause of diabetes and its intracellular impairment is practically the same in both types of diabetes. Diabetic patients will be recognized according to the state of impaired B cell. The antidiabetic drugs will be selected according to their effect protecting the B cells. Some antidiabetic drugs will be used more frequently in type 1 diabetes as well.Key words: antidiabetic drugs protecting B cell - B cell apoptosis - diabetes classification.
authors.forename: Jan
authors.initials: J
authors.lastname: Škrha
mesh_terms: D003920:Diabetes Mellitus / Q000145:classification* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000473:pathology*
chemical_list: D007004:Hypoglycemic Agents